MedPath

Acumapimod

Generic Name
Acumapimod
Drug Type
Small Molecule
Chemical Formula
C22H19N5O2
CAS Number
836683-15-9
Unique Ingredient Identifier
2F16KW647L
Background

Acumapimod is under investigation in clinical trial NCT02926326 (The Effect of Azithromycin on BCT197 Exposure in Healthy Male Volunteers).

Clinical Trials
Related News

The Effect of Itraconazole on BCT197 Exposure in Healthy Male Participants

Phase 1
Completed
Conditions
Interaction
Interventions
First Posted Date
2018-04-13
Last Posted Date
2018-05-18
Lead Sponsor
Mereo BioPharma
Target Recruit Count
16
Registration Number
NCT03498170
Locations
🇺🇸

inVentiv Health Clinical Research Services LLC, Miami, Florida, United States

The Effect of Azithromycin on BCT197 Exposure in Healthy Male Volunteers

Phase 1
Completed
Conditions
Interaction
Interventions
First Posted Date
2016-10-06
Last Posted Date
2016-10-24
Lead Sponsor
Mereo BioPharma
Target Recruit Count
16
Registration Number
NCT02926326
Locations
🇬🇧

BioKinetic Europe Ltd, Belfast, United Kingdom

Efficacy and Safety of BCT197 in Subjects With Acute Respiratory Exacerbations of Chronic Obstructive Pulmonary Disease

Phase 2
Completed
Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
Drug: Placebo
First Posted Date
2016-03-07
Last Posted Date
2020-11-30
Lead Sponsor
Mereo BioPharma
Target Recruit Count
282
Registration Number
NCT02700919
Locations
🇷🇺

Mereo Research Site, Tomsk, Russian Federation

Safety & Efficacy of BCT197A2201 in COPD Patients Presenting With an Exacerbation

Phase 2
Completed
Conditions
Chronic Obstructive Pulmonary Disease
Interventions
Drug: BCT197 placebo
First Posted Date
2011-04-08
Last Posted Date
2023-03-21
Lead Sponsor
Mereo BioPharma
Target Recruit Count
183
Registration Number
NCT01332097
Locations
🇷🇺

Novartis Investigative Site, St. Petersburg, Russian Federation

© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy